Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ling Tong, Xiangling Yu, Shan Wang, Ling Chen & Yibo Wu. (2023) Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer. Breast Cancer: Targets and Therapy 15, pages 647-658.
Read now
Read now
Wen-Jing Ning, Xue Liu, Hong-Ye Zeng, Zhi-Qiang an, Wen-Xin Luo & Ning-Shao Xia. (2022) Recent progress in antibody-based therapeutics for triple-negative breast cancer. Expert Opinion on Drug Delivery 19:7, pages 815-832.
Read now
Read now
Articles from other publishers (16)
Lexiang Shi, Yinan Zhang, Jingcheng Wu, Jinping Li, Junzhao Zhu, Youbo Xu, Nie Li, Qin Li & Wanli Zhang. (2023) A case report and literature review on a rare subtype of triple-negative breast cancer in children. BMC Pediatrics 23:1.
Crossref
Crossref
Uttpal Anand, Abhijit Dey, Arvind K. Singh Chandel, Rupa Sanyal, Amarnath Mishra, Devendra Kumar Pandey, Valentina De Falco, Arun Upadhyay, Ramesh Kandimalla, Anupama Chaudhary, Jaspreet Kaur Dhanjal, Saikat Dewanjee, Jayalakshmi Vallamkondu & José M. Pérez de la Lastra. (2023) Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes & Diseases 10:4, pages 1367-1401.
Crossref
Crossref
Yang Gao, Chuanzhen Bian, Kang Gu, Haiyan Wang, Shan Zhuang, Xiaowen Tang & Yunian Zhao. (2023) Patterns of distant metastases in patients with triple‐negative breast cancer—A population‐based study. Precision Medical Sciences.
Crossref
Crossref
Ziwei Zhao, Xue Han, Chen Nie, Shan Lin, Jingwei Wang & Hong Fang. (2023) Circ_0008784 activates Wnt/β-catenin pathway to affect the proliferation and apoptosis of triple-negative breast cancer cells. Pathology - Research and Practice 241, pages 154185.
Crossref
Crossref
Avinash Khadela, Shruti Soni, Kaivalya Megha, Aayushi C. Shah, Aanshi J. Pandya, Nirjari Kothari, Ishika Shah & C. B. Avinash. (2022) Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects. Medical Oncology 40:1.
Crossref
Crossref
Ali Ameri, Bahareh Tavakoli-Far, Maryam Rostami, Bahman Abedi kiasari, Delaram Sakhaei, Omar Saad Ahmed, Fatemeh Forouzani & Yasaman Fazli. (2022) Recent advances in atezolizumab-based programmed death-ligand 1 (PD-L1) blockade therapy for breast cancer. International Immunopharmacology 113, pages 109334.
Crossref
Crossref
Rachel Martini, Princesca Delpe, Timothy R. Chu, Kanika Arora, Brittany Lord, Akanksha Verma, Deepa Bedi, Balasubramanyam Karanam, Isra Elhussin, Yalei Chen, Endale Gebregzabher, Joseph K. Oppong, Ernest K. Adjei, Aisha Jibril Suleiman, Baffour Awuah, Mahteme Bekele Muleta, Engida Abebe, Ishmael Kyei, Frances S. Aitpillah, Michael O. Adinku, Kwasi Ankomah, Ernest Baawuah Osei-Bonsu, Dhananjay A. Chitale, Jessica M. Bensenhaver, David S. Nathanson, LaToya Jackson, Lindsay F. Petersen, Erica Proctor, Brian Stonaker, Kofi K. Gyan, Lee D. Gibbs, Zarko Monojlovic, Rick A. Kittles, Jason White, Clayton C. Yates, Upender Manne, Kevin Gardner, Nigel Mongan, Esther Cheng, Paula Ginter, Syed Hoda, Olivier Elemento, Nicolas Robine, Andrea Sboner, John D. Carpten, Lisa Newman & Melissa B. Davis. (2022) African Ancestry–Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent. Cancer Discovery 12:11, pages 2530-2551.
Crossref
Crossref
Sunil Kumar Surapaneni, Nilkumar Patel, Li Sun, Nagavendra Kommineni, Anil Kumar Kalvala, Aragaw Gebeyehu, Peggy Arthur, Leanne C. Duke, Ramesh Nimma, David G MeckesJrJr & Mandip Singh. (2022) Anticancer and chemosensitization effects of cannabidiol in 2D and 3D cultures of TNBC: involvement of GADD45α, integrin-α5, -β5, -β1, and autophagy. Drug Delivery and Translational Research 12:11, pages 2762-2777.
Crossref
Crossref
Kalani M. Wijesinghe, Mazhar A. Kanak, J. Chuck Harrell & Soma Dhakal. (2022) Single-Molecule Sensor for High-Confidence Detection of miRNA. ACS Sensors 7:4, pages 1086-1094.
Crossref
Crossref
Meng Wang, Di Chen, Hanchao Zhang & Chengyu Luo. (2022) Circular RNA circPTK2 modulates migration and invasion via miR-136/NFIB signaling on triple-negative breast cancer cells in vitro. Inflammation Research 71:4, pages 409-421.
Crossref
Crossref
Guillermo Arturo Valencia, Patricia Rioja, Zaida Morante, Rossana Ruiz, Hugo Fuentes, Carlos A Castaneda, Tatiana Vidaurre, Silvia Neciosup & Henry L Gomez. (2022) Immunotherapy in triple-negative breast cancer: A literature review and new advances. World Journal of Clinical Oncology 13:3, pages 219-236.
Crossref
Crossref
Uzini Devi Daimary, Sosmitha Girisa, Dey Parama, Elika Verma, Aviral Kumar & Ajaikumar B. Kunnumakkara. (2021) Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases. Journal of Biochemical and Molecular Toxicology 36:2.
Crossref
Crossref
Hongming Song, Haibo Wang, Mingkai Gong, Li Wu, Xiangping Liu, Weihong Cao, Xueqiang Gao, Rongrong Dou, Qiaoyu Chen & Haiyan Hu. (2021) Augmentation of antitumor function of tumor‐infiltrating lymphocytes against triple‐negative breast cancer by PD‐1 blockade. Cell Biology International 46:2, pages 278-287.
Crossref
Crossref
Na Zhao, Wenwen Zhu, Jia Wang, Weiwei Liu, Longdan Kang, Rui Yu & Beixing Liu. (2021) Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model. International Immunopharmacology 99, pages 107924.
Crossref
Crossref
Weihua Jiang, Xiao-Liang Xing, Chenguang Zhang, Lina Yi, Wenting Xu, Jianghua Ou & Ning Zhu. (2021) MET and FASN as Prognostic Biomarkers of Triple Negative Breast Cancer: A Systematic Evidence Landscape of Clinical Study. Frontiers in Oncology 11.
Crossref
Crossref
José Pérez-García, Patricia Cortez, María Gion & Javier Cortés. (2020) Can we cure oligometastatic disease? A practical point of view. Current Opinion in Oncology 32:6, pages 568-574.
Crossref
Crossref